Company Filing History:
Years Active: 2020-2025
Title: Veronica Gough: Innovator in Hepatitis B Research
Introduction
Veronica Gough is a prominent inventor based in Durham, NC (US). She has made significant contributions to the field of biotechnology, particularly in the regulation of Hepatitis B virus through innovative gene repression techniques. With a total of 6 patents, her work is paving the way for new therapeutic approaches to combat viral infections.
Latest Patents
One of her latest patents focuses on "Compositions, systems, and methods for regulation of Hepatitis B virus through targeted gene repression." This invention provides epigenetic-modifying DNA-targeting systems, such as CRISPR-Cas/guide RNA (gRNA) systems, aimed at the transcriptional repression of Hepatitis B viral (HBV) genes. The goal is to promote a cellular phenotype that leads to the reduction of HBV infection. The systems are designed to bind to or target specific sites within the Hepatitis B viral DNA sequence, thereby repressing viral replication and expression.
Career Highlights
Throughout her career, Veronica has worked with notable organizations, including Tune Therapeutics, Inc. and William Marsh Rice University. Her research has been instrumental in advancing our understanding of viral gene regulation and its implications for treatment strategies.
Collaborations
Veronica has collaborated with several professionals in her field, including Brian Cosgrove and Kendra Congdon. These partnerships have enhanced her research efforts and contributed to the development of innovative solutions for Hepatitis B treatment.
Conclusion
Veronica Gough's work exemplifies the impact of innovative research in the fight against viral infections. Her contributions to the field of biotechnology are significant and continue to inspire future advancements in medical science.